NCT03515694View on ClinicalTrials.gov

Minimal Optimal Dose of Sugammadex in Elective Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Time of a TOF Ratio >0,9
Interventions
DRUG

Sugammadex Injection [Bridion]

Injection of 10mL of translucide solution

Trial Locations (1)

1070

Hopital Erasme, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT03515694 - Minimal Optimal Dose of Sugammadex in Elective Surgery | Biotech Hunter | Biotech Hunter